Stock Split News

WASHINGTON--(BUSINESS WIRE)--FiscalNote Files Preliminary Information Statement to Authorize Process for Potential Reverse Stock Split at Board’s Discretion...

CAMPBELL, Calif.--(BUSINESS WIRE)--ChargePoint (NYSE: CHPT the “Company”), a leading provider of EV charging solutions, announced that today the Company implemented a reverse stock split of its common stock at a ratio of 1-for-20, which will be reflected at market open. The reverse stock split is intended to increase the market price per share of the Company’s common stock and help the Company comply with the minimum trading price criteria for continued listing on the New York Stock Exchange (t...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (OTCQB: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that it will implement a 1-for-75 reverse stock split of its issued and outstanding shares of common stock (“Reverse Stock Split”), effective at 5:00 p.m. Eastern Time on August 4, 2025. The Reverse Stock Split was approved by the compa...

WHEATON, Ill.--(BUSINESS WIRE)--First Trust Advisors L.P. (“FTA”) announced yesterday that the Board of Trustees of First Trust Exchange-Traded Fund VIII, on behalf of FT Confluence BDC & Specialty Finance ETF (the “Fund”), an actively-managed exchange-traded fund (NYSE Arca: FBDC), approved a 1-for-5 reverse share split. After the reverse share split, the Fund’s shares will continue to trade under the same ticker symbol, FBDC. The Fund’s current CUSIP number (33740F110) will be replaced by...

WHEATON, Ill.--(BUSINESS WIRE)--First Trust Advisors L.P. (“FTA”) announced today that the Board of Trustees (the “Board”) of First Trust Exchange-Traded Fund VIII (the “Trust”), on behalf of FT Confluence BDC & Specialty Finance ETF (the “Fund”), an actively-managed exchange-traded fund (NYSE Arca: FBDC), approved a 1-for-5 reverse share split. The reverse share split will result in every five outstanding shares of the Fund being converted into one share of the Fund, with any resulting fra...

BARCELONA, Spain--(BUSINESS WIRE)--Wallbox (NYSE: WBX) today announced that it is expected to implement a 20-for-1 reverse stock split of all classes of the Company’s ordinary shares. The reverse stock split is intended to bring the Company into compliance with the minimum bid price requirement set by the New York Stock Exchange (“NYSE”). Wallbox shareholders approved at the Company’s Annual General Meeting held on June 30, 2025 (“AGM”) a reverse stock split ratio within a range of 1-for-10 to...

SAN DIEGO--(BUSINESS WIRE)--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), announced today that, on July 7, 2025, the Company will implement a 1-for-3 reverse split of its common stock following approval at its Special Meeting of Stockholders held on June 23, 2025. The reverse stock split will be effective as of the morning of July 7, 2025, and the Company’s common stock will trade on a post-split basis at the beginning of trading on the same date under the existin...

WALTHAM, Mass.--(BUSINESS WIRE)--Pegasystems Inc. (NASDAQ: PEGA), The Enterprise Transformation Company™, announced that shareholders approved an increase in authorized shares at today's annual shareholder meeting to enable a two-for-one stock split to make the stock more accessible to a broader base of investors and employees. The two-for-one stock split will be issued after the close of business on June 20, 2025, and trading will begin on a split-adjusted basis on June 23, 2025. Following the...

PHILADELPHIA--(BUSINESS WIRE)--Armada Acquisition Corp. II (NASDAQ: AACIU) (the “Company”) announced today that, commencing June 24, 2025, holders of the 23,000,000 units sold in the Company’s initial public offering may elect to separately trade shares of the Company’s Class A ordinary shares and warrants included in the units. The Class A ordinary shares and warrants that are separated will trade on the Nasdaq Stock Market LLC (“Nasdaq”) under the symbols “AACI” and “AACIW”, respectively. No...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (OTC: SPRB) (“Spruce”), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, announced that it has received approval from The Nasdaq Stock Market LLC (“Nasdaq”) to resume trading of its common stock on the Nasdaq Capital Market subject to Spruce regaining compliance with Nasdaq’s minimum bid price requirement on or bef...